May 3, 2004
In Print Photo by Leah Gourley From Focus: Curtain Drawn on Hormone Therapy for Older Women For women age 60 and older, the risks of hormone therapy appear to outweigh the benefits, says JoAnn Manson. The latest results from the estrogen-only arm of the Women's Health Initiative mark an overwhelming reversal of a decades-old effort to market hormone treatment as a way to prevent chronic diseases of aging, especially heart disease. Yet the same results suggest a cardiovascular benefit for women younger than 60 who start estrogen therapy at menopause.   Publications Online BBS Bulletin Focus HMI World HSTconnector MD-PhD Newsletter MedEd News Mentations On The Brain   Related Links InteliHealth Harvard Health Publications		Headlines Clinical Trial Participants Often Do Not Receive Trial Results Study Identifies Which Patients Can Benefit from Targeted Lung Cancer Drug, and Why Gene Mutations Predict Which Lung Cancers Will Respond to Iressa Physicians Have Mixed Opinions About Consumer-targeted Pharmaceutical Ads Testosterone Replacement Improves Muscle Strength, Function in HIV-infected Women Upcoming Challenges in Health Policy A Panel with Michael Dukakis Wednesday, May 12 5:00-6:00 p.m. Lessons from the Community: A Conference to Promote Partnerships for Environmental Health and Justice Klare X. Allen Saturday, May 15 9:00 a.m.-3:00 p.m.		Spotlight   Alumni Week Program and Registration Available Online Alumni Week and class reunion events begin on Wednesday, June 9. See the link for more information and online registration. Student Scene   Fulfilling the Mission: Student Perspectives In a May 12 program, students in the Medical School and Division of Medical Sciences will tell their stories about their personal paths toward clinical care and research. Lab Works A multimedia site featuring Harvard Medical research.

Calendar | Jobs | Harvard Medical School Home | Hospitals | Back Issues | Feedback | Home Copyright 2004 by the President and Fellows of Harvard College